Peter Cicala - 26 Apr 2024 Form 4 Insider Report for Eterna Therapeutics Inc. (ERNA)

Role
Director
Signature
/s/ Peter Cicala
Issuer symbol
ERNA
Transactions as of
26 Apr 2024
Net transactions value
$0
Form type
4
Filing time
29 Apr 2024, 16:31:01 UTC
Previous filing
16 Feb 2024
Next filing
10 Feb 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ERNA Stock Option (Right to buy) Award $0 +88,946 $0.000000 88,946 26 Apr 2024 Common Stock 88,946 $1.74 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option shall vest as to 100% of the number of shares subject to the stock option on the one-year anniversary of the grant date.